Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: Prog Retin Eye Res. 2020 Sep 4;82:100901. doi: 10.1016/j.preteyeres.2020.100901

Table 3.

Prostaglandin eye drops and clinically advanced or late stage sustained release delivery systems. Dose ratio relative to intracameral route is included for bimatoprost, the most clinically successful prostaglandin for sustained delivery.

Route Product Manufacturer Strength/ Total dose/ Frequency Daily dose (μg/Day) Dose (μg/180 Days Dose ratio relative to intracameral
Bimatoprost
Topical eye drop solution Lumigan Allergan 0.1 mg/mL or 0.3 mg/mL, 1 drop q.d. (pm) 5 μg/Day or 15 μg/Day 900 or 2700 μg 45 or 135
Conjunctival fornix insert Fornix ring insert Allergan 13 mg, 1 insert, delivers for 6 months To - 35 μg/Day
T180 - 6
μg/Day
13,000 650
Intracameral implant Durysta Allergan 10 μg, 1 implant, delivers for 3 months 0.1 μg/Day to 0.9 μg/Day 20 1
Latanoprost
Topical eye drop solution Xalatan Pfizer 50 μg/mL 2.5 μg/Day
Topical nondegradable insert Eye-D VS101 BioLight Life Sciences Ltd. High, medium, and low doses, delivers for 3 months N/A+
Punctum or nasolacrimal duct plug L-PPDS Punctal plug Mati Therapeutics Low dose: 70.5 μg (1 plug)
High dose:141 μg (2 plugs), delivers for 4 weeks
3.0 μg/Day*
EXP-LP Punctal plug Eximore, Ltd. Low dose: 250 μg
High dose: 450 μg
1.38 μg/Day
2.50 μg/Day
Intracameral implant PA5108 For latanoprost free acid PolyActiva Study 1 doses - 8.9, 14.7, 26.6, and 35.5 μg.
Study 2 doses – 16.2, 30, 45, and 60 μg, delivers for
3 months
N/A+
Travoprost
Topical eye drop solution Travatan Z Novartis 40 μg/mL 2 μg/Day
Punctum or nasolacrimal duct plug OTX-TP2 Ocular Therapeutix N/A, delivers for 2 or 3 months N/A+
Sclera-anchored implant iDose Glaukos Corp. Two doses, delivers for 6–12 months N/A+
Intracameral implant Travoprost XR-ENV515 OTX-TIC Envisia Therapeutics
Ocular Therapeutix
42.5 μg, delivers for 6–12 months
N/A, delivers for 3 months
N/A+
N/A+
*

Punctal plugs were designed to release drug at this rate

+

Not available